Drugs / Danlou Tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03072082 | Jun 2017 → Dec 2018 | coronary artery disorder | Jun Li | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danlou Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03072082 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Danlou Tablet, a kind of Chinese patent medicine” NCT03072082 ↗ |
| Route | Oral | “Danlou 0.3g tablet by mouth” NCT03072082 ↗ |